Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFirst Affiliated Hospital Xi'an Jiaotong University
About this trial
This study aims to evaluate the incidence, clinical characteristics, and short-term prognosis of acute cerebrovascular events occurring in-hospital in patients with arrhythmias following catheter ablation. The goal is to provide evidence supporting the improvement of patient quality of life and reduction of in-hospital acute cerebrovascular complications in patients with post-ablation arrhythmias. This will also contribute to the evidence-based clinical management of such patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
1.Patients who undergo catheter ablation for arrhythmias.
Disqualifiers
1. Patients were diagnosed of acute cerebrovascular disease prior to radiofrequency catheter ablation;
2. Patients < 18 years or > 80 years;
3. Patients with uncomplete clinical data.
Trial population
This study plans to enroll patients with arrhythmias who undergo catheter ablation and meet the specified inclusion and exclusion criteria.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
2,000 Participants
are grouped into 4 trial groupsGroup A: Ischemic stroke group
Group B: Transient ischemic attack group
Group C: Cerebral hemorrhage group
Group D: Contral group
Trial outcomes
Primary outcomes
1
Incidence of MACCE
Major adverse cardiovascular and cerebrovascular events, a composite of all-cause mortality, myocardial infarction and stroke. The data will be obtained at 3-month follow-up, according to medical records of all patients.
Time frame
3 months after enrollmentSecondary outcomes
1
Incidence of all-cause mortality
The data will be obtained at 3-month follow-up, according to medical records of all patients.
Time frame
3 months after enrollment2
Incidence of myocardial infarction
The data will be obtained at 3-month follow-up, according to medical records of all patients.
Time frame
3 months after enrollment3
Incidence of stroke
The data will be obtained at 3-month follow-up, according to medical records of all patients.
Time frame
3 months after enrollmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
First Affiliated Hospital Xi'an Jiaotong University
Lead sponsor
Shaanxi Provincial People's Hospital
Collaborator
521 Hospital of NORINCO Group
Collaborator
Xiangyang Central Hospital
Collaborator
Ankang Central Hospital
Collaborator
Baoji Central Hospital
Collaborator
Luoyang Central Hospital
Collaborator
Tianjin Medical University Second Hospital
Collaborator
Fu Wai Hospital, Beijing, China
Collaborator
Fuwai Yunnan Cardiovascular Hospital
Collaborator
Chinese Academy of Medical Sciences, Fuwai Hospital
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: